Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection

A technology of cefoperazone sodium and tazobactam sodium, which is applied in the field of medicine, can solve the problems of undisclosed cefoperazone sodium and sulbactam sodium, and achieve the effects of good stability, improved stability and high encapsulation efficiency

Inactive Publication Date: 2010-12-15
HAINAN LINGKANG PHARMA CO LTD
View PDF30 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The microsphere preparation of cefoperazone sodium sulbactam sodium is not disclosed in the prior art, and the pharmaceutical composition of excellent cefoperazone sodium sulbactam sodium is still needed in this field, which has excellent slow-release characteris...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection
  • Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection
  • Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection, which is characterized by comprising 4 to 8 weight parts of cefoperazone sodium, 1 to 2 weight parts of tazobactam sodium, 2.5 to 5 weight parts of PLA, 1.25 to 2.5 weight parts of Span60, 1 to 2 weight parts of glycerol monostearate and 1 to 2 weight parts of glucose. Compared with the prior art, the cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection of the invention has the advantages of high stability, high entrapment rate, high-repeatability preparation process suitable for industrial production, uniform particle distribution, little solvent residue, high injectability and good sustained-release property.

Description

technical field The invention relates to a cefoperazone sodium tazobactam sodium pharmaceutical composition microsphere injection, which belongs to the technical field of medicine. Background technique Cefoperazone is a third-generation cephalosporin antibiotic that achieves bactericidal effect by inhibiting the biosynthesis of sensitive bacterial cell walls. Tazobactam has no antibacterial activity against other bacteria except Neisseriaceae and Acinetobacter, but tazobactam has activity against most important β-lactamases produced by β-lactam antibiotic-resistant strains Irreversible inhibition. Tazobactam can prevent drug-resistant bacteria from destroying penicillins and cephalosporins, and tazobactam has obvious synergistic effects with penicillins and cephalosporins. The compound preparation of cefoperazone sodium and tazobactam sodium has been sold in China at present, and all of them are directly packaged as aseptic powder. The common defect is that the preparatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/546A61K31/431A61K9/16A61K47/34A61P31/04A61K47/26
Inventor 陶灵刚
Owner HAINAN LINGKANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products